炎症性肠病治疗市场基于(关键地区、市场参与者、规模和份额)- 到 2031 年的预测

  • Report Code : TIPRE00003491
  • Category : Pharmaceuticals
  • Status : Data Released
  • No. of Pages : 150
Buy Now

市场概览

炎症性肠病 (IBD) 是一个术语,用于描述涉及消化道慢性炎症的疾病。 IBD 的两种类型包括溃疡性结肠炎和克罗恩病,通常涉及严重腹泻、腹痛、疲劳和体重减轻。 IBD 的治疗是减少引发体征和症状的炎症。治疗包括药物治疗或手术治疗。药物治疗包括抗炎药,还包括皮质类固醇和氨基水杨酸盐,例如美沙拉嗪(Asacol HD、Delzicol 等)、巴柳氮 (Colazal) 和奥沙拉嗪 (Dipentum),具体取决于受影响的结肠区域。< /p>

市场范围

“全球炎症《2028年肠道疾病治疗市场分析》是对医疗器械行业的专业、深入的研究,特别关注全球市场趋势分析。该报告旨在概述炎症性肠病治疗市场,并按药物类别类型、疾病适应症、分销渠道和地理位置进行详细的市场细分。该报告提供了主要炎症性肠病治疗市场参与者的市场状况的关键统计数据,并提供了市场的主要趋势和机会。

市场细分

  • 根据药物类别类型,市场分为氨基水杨酸盐、免疫调节剂、TNF 抑制剂和皮质类固醇。
  • 根据疾病适应症,市场分为克罗恩病和溃疡性结肠炎
  • 根据分销渠道,全球炎症性肠病治疗市场分为医院药房、在线药房和零售药房。
< p 样式=“行高:150%;边距:0in 0in 8pt;字体大小:11pt;字体系列:Calibri,无衬线;">

市场动态

驱动程序:

  • 治疗炎症性肠病 (IBD) 的强大管道产品
  • 克罗恩病和溃疡性结肠炎的患病率上升

限制:

  • 治疗费用高昂

区域框架

该报告提供了该行业的详细概述,包括定性和定量信息。它提供了基于各个细分市场的全球市场的概述和预测。它还提供了市场规模并对2019年至2028年五个主要地区(即北美、欧洲、亚太地区(APAC)、中东和非洲(MEA)以及南美洲)的炎症性肠病治疗市场进行了预测。每个区域随后根据各自的国家和细分市场进行细分。报告涵盖了全球 18 个国家的分析和预测以及该地区当前的趋势和机遇。

报告从需求和供给两个方面分析了影响市场的因素,并进一步评估了预测期内影响市场的市场动态,即驱动因素、限制因素、机会和未来趋势。在评估了影响这些地区炎症性肠病治疗市场的政治、经济、社会和技术因素后,该报告还对所有五个地区(即北美、欧洲、亚太地区、MEA 和南美洲)进行了详尽的 PEST 分析。

COVID-19 对炎症性肠病治疗市场的影响

COVID-19 于 2019 年 12 月首次在中国武汉爆发,此后在全国范围内快速传播从确诊病例和报告死亡人数来看,美国、印度、巴西、俄罗斯、法国、英国、土耳其、意大利和西班牙是受影响最严重的国家。COVID-19 大流行增加了对炎症性肠病的需求全球治疗。

由于 COVID 19 的情况,许多公司专注于开发有效的疫苗、生物制剂和药物来预防/治疗该疾病。然而,由于其他药品或生物制品的开发和制造放缓,加上供应链中断,市场在 2020 年遇到了困难。此外,由于封锁的一些限制,对 IBD 儿童的护理一直保持在最低标准,优先考虑紧急情况和生物制剂输注并实施远程医疗服务。

市场参与者

该报告涵盖了炎症性肠病治疗市场的有机和无机增长战略的主要发展。各个公司都专注于有机增长战略,例如产品发布、产品批准等例如专利和事件。市场中见证的无机增长战略活动是收购、伙伴关系和合作。这些活动为市场参与者的业务和客户群的扩展铺平了道路。预计炎症性肠病治疗市场的市场支付者随着全球市场对炎症性肠病治疗的需求不断增长,未来将获得利润丰厚的增长机会。

该报告还包括关键公司的概况及其在炎症性肠病治疗市场中的 SWOT 分析和市场策略。此外,该报告还重点关注了领先的行业参与者公司简介、提供的组件和服务、过去 3 年的财务信息、过去 5 年的主要发展等信息。

  • 辉瑞公司
  • 诺华公司
  • JOHNSON 和 JOHNSON (Janssen Global Services, LLC)
  • 艾伯维公司
  • 武田药品工业株式会社
  • ALLERGAN
  • CELGENE CORPORATION
  • Bausch Health
  • UCB, Inc.
  • Cosmo Pharmaceuticals NV

Insight Partner 的专业研究和分析团队由经验丰富的专业人士组成,拥有先进的统计专业知识,并在现有研究中提供各种定制选项。

Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What is inflammatory bowel disease?

Inflammatory bowel disease" (IBD) is a chronic inflammatory condition of the gastrointestinal tract, including Crohn's disease and ulcerative colitis. These conditions cause inflammation of the digestive tract lining, leading to symptoms like abdominal pain, diarrhea, fatigue, and weight loss. Treatment aims to reduce inflammation, manage symptoms, and prevent complications through medication, lifestyle changes, and sometimes surgery. Managing IBD typically requires ongoing medical care and monitoring to maintain remission and improve quality of life.

What factors drive the Inflammatory Bowel Disease Treatment Market?

The key factors driving the Inflammatory Bowel Disease Treatment Market growth are the rising prevalence of crohn's disease and ulcerative colitis and increasing product launches over the projection period. Inflammatory Bowel Disease Treatment Market trends include the technological advancement in IBD treatment. Furthermore, the development of innovative treatments through continuing research as well as encouraging government initiatives are also expected to fuel the market growth.

Who are the major players in the Inflammatory Bowel Disease Treatment Market?

The Inflammatory Bowel Disease Treatment Market has major market players, including AbbVie Inc, Takeda Pharmaceutical Company Limited, Pfizer Inc, Biogen, Novartis AG, Lilly, UCB S.A., CELLTRION INC., Merck & Co., Inc., and Johnson & Johnson Services, Inc.

What was the estimated Inflammatory Bowel Disease Treatment Market size in 2023?

The Inflammatory Bowel Disease Treatment Market was valued at US$ 24.05 billion in 2023.

What are the growth estimates for the Inflammatory Bowel Disease Treatment Market till 2031?

The Inflammatory Bowel Disease Treatment Market is expected to be valued at US$ 31.67 billion in 2031.

Which drug class segment dominates the Inflammatory Bowel Disease Treatment Market?

Based on drug class, the market is segmented into biologics, aminosalicyclates, corticosteroids, and others. The biologics segment held the largest Inflammatory Bowel Disease Treatment Market share in 2023 and is anticipated to register the highest CAGR during 2023–2031.

Which disease indication segment dominates the Inflammatory Bowel Disease Treatment Market?

Based on disease indication, the Inflammatory Bowel Disease Treatment Market is segmented into crohn's disease and ulcerative colitis. The crohn's disease segment is anticipated to hold a significant share by 2031.

The List of Companies - Inflammatory Bowel Disease Treatment Market

  1. AbbVie Inc
  2. Takeda Pharmaceutical Company Limited
  3. Pfizer Inc
  4. Biogen
  5. Novartis AG
  6. Lilly
  7. UCB S.A.
  8. CELLTRION INC.
  9. Merck & Co., Inc.
  10. Johnson & Johnson Services, Inc.
  11. Mindray Medical International Limited

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports